It was déjà vu all over again for TV drug ad spending in August, as the top 10 spenders barely deviated from July’s list and turned in a combined total nearly identical to the preceding month’s haul.

In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad spending has crept downward as 2025 has gone on. According to data shared with ...

(Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and Rinvoq to $27 billion, up $6 billion from its previous prediction. The Chicago-based drugmaker has ...